Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

Similar articles for PubMed (Select 14684451)

1.

Glutamate and depression: clinical and preclinical studies.

Paul IA, Skolnick P.

Ann N Y Acad Sci. 2003 Nov;1003:250-72. Review.

PMID:
14684451
2.

Do glutamatergic agents represent a new class of antidepressant drugs? Part 1.

Sanacora G.

J Clin Psychiatry. 2009 Oct;70(10):1473-5. doi: 10.4088/JCP.09ac05680blu. Review. No abstract available.

PMID:
19906350
3.

The involvement of glutamate in the pathophysiology of depression.

Palucha A, Pilc A.

Drug News Perspect. 2005 May;18(4):262-8. Review.

PMID:
16034483
4.

The role of glutamate on the action of antidepressants.

Hashimoto K.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1558-68. doi: 10.1016/j.pnpbp.2010.06.013. Epub 2010 Jun 20. Review.

PMID:
20600468
5.

Metabotropic glutamate receptors in the control of mood disorders.

Witkin JM, Marek GJ, Johnson BG, Schoepp DD.

CNS Neurol Disord Drug Targets. 2007 Apr;6(2):87-100. Review.

PMID:
17430147
6.

On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.

Pałucha A, Pilc A.

Pol J Pharmacol. 2002 Nov-Dec;54(6):581-6. Review.

7.
8.

Glutamate-based antidepressants: 20 years on.

Skolnick P, Popik P, Trullas R.

Trends Pharmacol Sci. 2009 Nov;30(11):563-9. doi: 10.1016/j.tips.2009.09.002. Review.

PMID:
19837463
10.

AMPA receptors in the therapeutic management of depression.

Bleakman D, Alt A, Witkin JM.

CNS Neurol Disord Drug Targets. 2007 Apr;6(2):117-26. Review.

PMID:
17430149
11.

Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Kew JN, Kemp JA.

Psychopharmacology (Berl). 2005 Apr;179(1):4-29. Epub 2005 Feb 25. Review. Erratum in: Psychopharmacology (Berl). 2005 Oct;182(2):320.

PMID:
15731895
12.

AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.

Gartside SE, Cole AJ, Williams AP, McQuade R, Judge SJ.

Eur J Neurosci. 2007 May;25(10):3001-8. Epub 2007 May 17.

PMID:
17509083
13.

The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review.

Petrie RX, Reid IC, Stewart CA.

Pharmacol Ther. 2000 Jul;87(1):11-25. Review.

PMID:
10924739
14.

Mood disorders: regulation by metabotropic glutamate receptors.

Pilc A, Chaki S, Nowak G, Witkin JM.

Biochem Pharmacol. 2008 Mar 1;75(5):997-1006. doi: 10.1016/j.bcp.2007.09.021. Epub 2007 Oct 5. Review.

PMID:
18164691
15.

Are compounds acting at metabotropic glutamate receptors the answer to treating depression?

Palucha A.

Expert Opin Investig Drugs. 2006 Dec;15(12):1545-53. Review.

PMID:
17107280
16.

Do glutamatergic agents represent a new class of antidepressant drugs? Part 2.

Sanacora G.

J Clin Psychiatry. 2009 Nov;70(11):1604-5. doi: 10.4088/JCP.09ac05757blu. Review. No abstract available.

PMID:
20031105
17.

Emerging role of glutamate in the pathophysiology of major depressive disorder.

Hashimoto K.

Brain Res Rev. 2009 Oct;61(2):105-23. doi: 10.1016/j.brainresrev.2009.05.005. Epub 2009 May 28. Review.

PMID:
19481572
18.

mGluR5 is involved in dendrite differentiation and excitatory synaptic transmission in NTERA2 human embryonic carcinoma cell-derived neurons.

Park H, Váradi A, Seok H, Jo J, Gilpin H, Liew CG, Jung S, Andrews PW, Molnár E, Cho K.

Neuropharmacology. 2007 May;52(6):1403-14. Epub 2007 Feb 21.

PMID:
17395218
19.

Metabotropic glutamate receptor 1 activity generates persistent, N-methyl-D-aspartate receptor-dependent depression of hippocampal pyramidal cell excitability.

Clement JP, Randall AD, Brown JT.

Eur J Neurosci. 2009 Jun;29(12):2347-62. doi: 10.1111/j.1460-9568.2009.06780.x. Epub 2009 May 29.

PMID:
19490024
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk